GSA Capital Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

GSA Capital Partners’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,689	Closed	-$114K	–	2044
2022 Q3	$114K	Buy	+32,689	New	+$125K	0.02%	1344
2022 Q2	–	Sell	-31,675	Closed	-$289K	–	1968
2022 Q1	$289K	Buy	31,675 +29,738	+1,535%	+$452K	0.04%	919
2021 Q4	$42K	Buy	1,937 +975	+101%	+$26.1K	0.01%	1351
2021 Q3	$31K	Buy	+962	New	+$35.2K	﹤0.01%	1359
2020 Q3	–	Sell	-515	Closed	-$49K	–	1450
2020 Q2	$49K	Buy	+515	New	+$38.4K	0.03%	538
2016 Q3	–	Sell	-4,467	Closed	-$481K	–	2043
2016 Q2	$481K	Buy	+4,467	New	+$523K	0.03%	1099
2015 Q4	–	Sell	-5,746	Closed	-$979K	–	2029
2015 Q3	$979K	Buy	5,746 +1,198	+26%	+$230K	0.05%	648
2015 Q2	$881K	Buy	4,548 +3,078	+209%	+$571K	0.03%	1007
2015 Q1	$218K	Buy	+1,470	New	+$224K	0.01%	1888

Other funds holding SRGA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GSA Capital Partners's SRGA Position: Q4 2022 in Review

GSA Capital Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2022, closing a stake of 32,689 shares — an estimated $114K sold.

GSA Capital Partners first reported a position in SRGA in Q1 2015 and held it in 9 quarters. The position peaked at $979K in Q3 2015. 35 funds tracked by Wall St. Rank hold SRGA as of Q4 2022.

GSA Capital Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
GSA Capital Partners sold 32,689 Surgalign Holdings, Inc. Common Stock shares in Q4 2022, an estimated $114K.
GSA Capital Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
GSA Capital Partners's Surgalign Holdings, Inc. Common Stock position peaked at $979K in Q3 2015.
35 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.